FDA releases further guidance on UDI; Device for gunshot wounds to hit market soon;

@FierceMedDev: Interesting: @Roche division @ventanamed helped shape a Dx masters degree program at @ArizonaState. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: Bid for Allergan puts Valeant's research and development cuts under scrutiny. More from the WSJ (sub. req.) | Follow @VarunSaxena2

@StacyALawrence: ICYMI yesterday: FDA panel to consider first drug-eluting balloon catheter. Story | Follow @StacyALawrence

@MichaelGFierce: Mayo Clinic team successfully delivers small molecules to the brain past blood-brain barrier. FierceDrugDelivery story | Follow @MichaelGFierce

@EmilyWFierce: Women who are pregnant or breastfeeding should eat at least 8 oz of fish a week, according to new #FDA guidelines. More from the NYT | Follow @EmilyWFierce

> FDA released new guidance on the global unique device identificaiton database today, June 11. Guidance

> FDA just released its device arm's plan of action based on Booz Allen Hamilton recommendations.Report

> RevMedx will soon begin distributing its device for healing gunshot wounds to military medics and other nonmilitary markets. Story

Biotech News

@FierceBiotech: Can Orexigen and its partner Takeda escape the weight-drug jinx? Yesterday's analysis | Follow @FierceBiotech

@JohnCFierce: Lilly's key franchise drug ramucirumab flops in PhIII liver cancer study. More | Follow @JohnCFierce

@DamianFierce: Crushing realization that @Forbes' "What To Wear at BIO" feature applies solely to women. More | Follow @DamianFierce

@EmilyMFierce: ICYMI yesterday: Today's edition of Research is out. Newsletter | Follow @EmilyMFierce

> Billionaire Thiel backs biotech startups with eyes on Alzheimer's, GI disease. Report

> Old Roche R&D campus in NJ faces the wrecking ball. Item

> Hostile Allergan bid is part of Valeant's war on 'value-destroying' R&D. Story

> Rebel AstraZeneca investors push plan to tie exec pay to rosy R&D projections. Article

Pharma News

@FiercePharma: Top-read on FP Tuesday: Shaky Dendreon loses its CEO as debt payments loom. Article | Follow @FiercePharma

@TracyStaton: Trending at FiercePharmaMarketing: Do reps push drugs off-label? Study says yes. Does it work? Also yes. More | Follow @TracyStaton

@EricPFierce: ICYMI from FiercePharmaManufacturing: New #FDA warning letter says Alabama compounder is making sterile drugs in unsanitary facility. Story | Follow @EricPFierce

@CarlyHFierce: Do reps push drugs off-label? Yes, a study suggests. Does it work? Also yes. FiercePharmaMarketing story | Follow @CarlyHFierce

@JustinHFierce: FDA voting today, tomorrow on opioid-induced constipation drug class, meds like Movantik could spell boom. More | Follow @JustinHFierce

> Italy's move to fund unapproved use of Roche's Avastin alarms the industry. Article

> Japanese authorities arrest ex-Novartis employee in data-manipulation scandal. Report

> Dartmouth profs take issue with calls for testosterone testing. Item

Pharma Marketing News

> Orexigen's weight-loss med sets up Takeda vs. Eisai marketing showdown--eventually. Article

> Feds cry foul at Allergan's free-speech defense in drug marketing case. Report

> New data backs GlaxoSmithKline's Incruse as an add-on to COPD med Breo Ellipta. Story

> Forest gives old Namenda a reprieve as switching to XR formula continues. More

> Men's Health Week or Low-T Week? Critics say awareness campaign is another pharma ploy. Article

Drug Delivery News

> UCSB study: New silver nanoparticles dissolve if they don't hit their mark. Article

> Avanir's nasal delivery for migraines beats oral sumatriptan in PhIIIb. Item

> Stem cells trapped in hydrogel better at bone repair. Story

> Cook launches Zilver PTX Drug-Eluting Stent in Canada. More

> Tonix receives IND approval for sublingual formulation to treat PTSD. Story

> Mayo Clinic team successfully delivers small molecules to the brain past blood-brain barrier. Article

Diagnostics News

> ImaginAb, Duke double down in Singapore on in vivo molecular imaging-agent work. More

> Roche's Ventana helped shape ASU's new Dx master's degree program. Story

> B. Braun will sell German partner's molecular Dx panels in the U.S. More

> China's FDA grants approval to Dehaier's portable sleep Dx system. Article

> AstraZeneca will tap Cancer Genetics' cancer biomarker testing tech in Central America. News

> Roche and MedImmune will concoct lung cancer immunotherapy clinical trial test. Item

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.